Grifols, a global health care company founded in Barcelona in 1909, develops innovative plasma-derived medicines and biopharmaceutical solutions to treat chronic, rare, and life-threatening conditions across diverse therapeutic areas. With the world’s largest network of donation centers and a comprehensive portfolio of transfusion and diagnostic solutions, Grifols is dedicated to improving health care worldwide through innovation, quality, and ethical leadership.
Grifols, a global health care company founded in Barcelona in 1909, develops innovative plasma-derived medicines and biopharmaceutical solutions to treat chronic, rare, and life-threatening conditions across diverse therapeutic areas. With the world’s largest network of donation centers and a comprehensive portfolio of transfusion and diagnostic solutions, Grifols is dedicated to improving health care worldwide through innovation, quality, and ethical leadership.
In this special sponsored episode, Dr. Thomas Ardiles, a pulmonary and critical care physician and medical director with Grifols, breaks down everything you need to know about alpha-1 antitrypsin deficiency. Discover why this genetic disorder often …